viewOpen Orphan PLC

Market report: FTSE mixed emotions over Brexit talks and further lockdown restrictions

FTSE 100 started on the backfoot even though the EU indicated its willingness to keep going with Brexit talks. London’s big cap index shed 13 points to 5,871 in early deals.

Greater Manchester may be placed in the most severe tier of restrictions if local leaders don’t find an agreement with Westminster by noon. The deadline comes after 10 days of discussions over financial support.

Heathrow, meanwhile, is introducing an optional rapid COVID-19 test for passengers flying to Hong Kong and Italy. It is the first such test available in the UK and costs £80. Housebuilder Bellway says orders at record levels and it is resuming dividends. Profits tumbled last year due to COVID-19, however, and the builder has set aside £47mln to beef up fire safety at its apartment blocks.

Among the small caps, Open Orphan’s  (LON:ORPH) hVIVO subsidiary has won a UK government contract worth up to £10mln to develop a coronavirus (COVID-19) human challenge study model to help speed up the development of a working vaccine. The model development involves the manufacture of the virus.

Symphony Environmental Technologies PLC (LON:SYM) said its French associate has completed a €6mln finance round for a green algae project. The proceeds will pay for the start of construction at Port St Louis, near Marseille.

Feedback PLC (LON:FDBK) is to team up with Axial Medical Printing to add 3D imaging to its flagship Bleepa medical imaging platform. Axial3D uses AI technologies to create 3D reconstructions of individual organs.

Quick facts: Open Orphan PLC

Price: 28.75 GBX

Market: AIM
Market Cap: £192.45 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...


Open Orphan to become '$1bln firm in very near future' after COVID-19 study...

Open Orphan PLC's (LON:ORPH) Cathal Friel talks to Proactive London's Katie Pilbeam about the world’s first COVID-19 characterisation study receiving approval from a specially convened Research Ethics Committee (REC).  This follows a contract received by the company’s subsidiary hVIVO...

1 week, 4 days ago

2 min read